Synthesis,crystal structure,spectral and electrochemical characterization,DNA binding and free radical scavenging studies of ferrocene-based thioureas

Abstract

Thioureas are important building blocks in medicinal chemistry; ferrocenes as highly hydrophobic moieties induce very interesting qualities in medicinal compounds. In this article, we have synthesized four ferrocene incorporated N,N′-disubstituted benzoyl thioureas (3a–3d) with general formula C₅H₅-Fe-C₅H₄C₆H₄Cl-NH-CS-NH-CO-C₆H₄(H/CH₃). Molecular structures of these compounds were characterized in solid and solution phases. In solution molecular structures were established by ¹H and ¹³C NMR and cyclic voltammetry. In the solid state their structures were characterized by elemental analyses and FTIR spectroscopy. Two of the compounds (3a and 3d) had also been structurally determined by single crystal X-ray diffraction analysis. The electrochemical characterization showed a reversible process with one electron transfer from Fe(II) to Fe(III). The single crystal analysis showed strong intermolecular non-covalent interactions in these compounds. Molecular structures of these compounds were also studied by density functional theory (DFT) calculation . DFT studies showed good correlation between calculated parameters and experimental results of solution phase and solid state characterizations. Compounds 3a–3d were evaluated for DNA interaction and antioxidant activity. These compounds interact with DNA via electrostatic forces and liberate significant binding constants and energies. Antioxidant potential –CSNH and –CONH groups induce same level of free radical scavenging ability in these compounds.     

Syntheses,structures and electrochemical properties of ruthenium(II/III) complexes with tetradentate Schiff base ligands

Three unsymmetrical tetradentate Schiff base ligands, H₂salipn, H₂salipn-Br₄ and H₂salipn-Cl₂, have been synthesized from the typical condensation reactions of treating 1,2-diaminopropane with salicylaldehyde, 3,5-dibromosalicylaldehyde and 5-chlorosalicylaldehyde, respectively. Treatment of [RuCl₂(PPh₃)₃] with one equivalent of H₂salipn or H₂salipn-Br₄ in the presence of triethylamine in tetrahydrofuran (THF) afforded the corresponding ruthenium(III) complexes [Ru^IIICl(PPh₃)(salipn)] (1) and [Ru^IIICl(PPh₃)(salipn-Br₄)] (2). Interaction of [RuHCl(CO)(PPh₃)₃] with one equivalent of H₂salipn-Cl₂ or H₂salipn-Br₄ under the same conditions led to isolation of ruthenium(II) complexes [Ru^II(CO)(PPh₃)(salalipn-Cl₂)] (3) and [Ru^II(CO)(PPh₃)(salalipn-Br₄)] (4), respectively, in which one of the imine bonds was nucleophilically attacked by hydride to result in the formation of a mixed imine-amine ligand. The molecular structures of 1?1.5CH₂Cl₂, 2, 3?0.5CH₂Cl₂ and 4 have been determined by single-crystal X-ray crystallography. The electrochemical properties of 1–4 were also investigated. Their cyclic voltammograms displayed quasi-reversible Ru(IV)/Ru(III) and Ru(III)/Ru(II) couples with E^o ranging from 0.67 to 1.05 V and 0.74 to 0.80 V vs. Ag/AgCl (0.1 M), respectively.     

Ruthenium(III)-carbonyl and ruthenium(II)-nitrosyl complexes of nitrogen-containing ligands with ethoxysilane groups

Reactions of γ-aminopropyltriethoxysilane and 4-(diethylamino)salicylaldehyde in ethanol afforded a Schiff base L1H, which reacted with [Ru(CO)₂Cl₂]_n in the presence of Et₃N in THF giving a ruthenium(III) carbonyl complex RuCl(CO)₂(η¹-O-L1)(η²-O,N-L1) (1). Treatment of γ-aminopropyltriethoxysilane with 4-pyridinecarboxaldehyde gave the Schiff base L2. Interactions of L2, γ-aminopropyltriethoxysilane, and Ru(NO)Cl₃?H₂O in THF led to the formation of a ruthenium(II) nitrosyl complex RuCl₃(NO)(L2)[H₂N(CH₂)₃Si(OEt)₃] (2) with linear N≡O ligand. Complexes 1 and 2 were characterized by microanalyses and IR and MS spectroscopies and confirmed by single-crystal X-ray diffraction.     

Pyridine-2-olato chelated ruthenium(II) organometallics incorporating imine-phenol function: spectroscopic,structural, electrochemical,and theoretical studies

The heterogeneous phase reaction of excess sodium salt of 2-hydroxypyridine (OHpy) with [Ru(κ²C,O-RL)(PPh₃)₂(CO)Cl] (1) afforded complexes of the type [Ru(κ¹C-RL)(PPh₃)₂(CO)(Opy)] (2) in excellent yield [κ²C,O-RL is 4-methyl-6-((N-R-arylimino)methyl)phenolato-C²,O), κ¹C-RL is 4-methyl-6-((N-R-arylimino)methyl)phenol-C²) and R is H, Me, OMe, Cl]. The chelation of Opy is attended with the cleavage of Ru-O and Ru-Cl bonds and iminium-phenolato → imine-phenol prototropic shift. The 1→2 conversion is irreversible and the type 2 species are thermodynamically more stable than the acetate, nitrite, and nitrate complexes of 1. The spectral (UV-vis, IR, NMR) and electrochemical data of the complexes are reported. In dichloromethane solution the complexes display one quasi-reversible Ru^III/Ru^II cyclic voltammetric response with E_1/2 in the range 0.65–0.69 V versus Ag/AgCl. The crystal and molecular structures of [Ru(κ¹C-HL)(PPh₃)₂(CO)(Opy)]·2C₆H₆·0.5H₂O, 2(H)·2C₆H₆·0.5H₂O and [Ru(κ¹C-ClL)(PPh₃)₂(CO)(Opy)]·2C₆H₆·0.25H₂O, 2(Cl)·2C₆H₆·0.25H₂O are reported, which revealed a distorted octahedral RuC₂P₂NO coordination sphere. The pairs (P,P), (C,O), and (C,N) define the three trans directions. The electronic structures of the complexes are also scrutinized by density functional theory.     

Syntheses,characterization, and crystal structures of ruthenium(II)/(III) complexes with tridentate salicylaldiminato ligands

Treatment of [Ru(PPh₃)₃Cl₂] with one equivalent of tridentate Schiff base 2-[(2-dimethylamino-ethylimino)-methyl]-phenol (HL) in the presence of triethylamine afforded a ruthenium(III) complex [RuCl₃(κ²-N,N-NH₂CH₂CH₂NMe₂)(PPh₃)] as a result of decomposition of HL. Interaction of HL and one equivalent of [RuHCl(CO)(PPh₃)₃], [Ru(CO)₂Cl₂] or [Ru(tht)₄Cl₂] (tht = tetrahydrothiophene) under different conditions led to isolation of the corresponding ruthenium(II) complexes [RuCl(κ³-N,N,O-L)(CO)(PPh₃)] (2), [RuCl(κ³-N,N,O-L)(CO)₂] (3), and a ruthenium(III) complex [RuCl₂(κ³-N,N,O-L)(tht)] (4), respectively. Molecular structures of 1·CH₂Cl₂, 2·CH₂Cl₂, 3 and 4 have been determined by single-crystal X-ray diffraction.     

Crystal structures,electrochemical properties,antioxidant screening and in vitro cytotoxic studies on four novel Cu(II) complexes of bidentate Schiff base ligands derived from 2-methoxyethylamine

Four novel Schiff base ligands and their copper(II) complexes, [Cu(L¹)₂] (1), [Cu(L²)₂] (2), [Cu(L³)₂] (3), and [Cu(L⁴)₂] (4), were synthesized and characterized by elemental analyses, FT-IR, and UV–Vis spectroscopy. The ligands were synthesized from the condensation of 2-methoxyethylamine with various salicylaldehyde derivatives (x-salicylaldehyde for HLⁿ, x = H (n = 1), 5-Br (n = 2), 3-OMe (n = 3), and 4-OMe (n = 4)). The molecular structures of 1, 2, and 3 were determined by the single crystal X-ray diffraction technique. The redox behavior studies of the complexes in acetonitrile display the electronic effects of the groups on the redox potential. The antioxidant activity of the Schiff base ligands and their Cu(II) complexes was evaluated using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging method and FRAP assay. Furthermore, the in vitro anticancer activity of compounds was screened, including MTT and migration assays against gastric cancer cell line (MKN-45). The results show that all ligands and complexes have antioxidant and anticancer activity in a concentration-dependent way.     

Spectroscopic,structural, electrochemical,and cytotoxicity studies on dithiocarbamato-chelated ruthenium organometallics incorporating imine-phenol function

The heterogeneous phase reaction of [Ru(η²-RL)(PPh₃)₂(CO)Cl] (1) with the sodium salts of dimethyl dithiocarbamate (^MeDTC), diethyl dithiocarbamate (^EtDTC), and pyrrolidine dithiocarbamate (^PyrDTC) ligands led to the isolation of bright-yellow crystalline solids of type [Ru(η¹-RL)(PPh₃)₂(CO)(^R′DTC)] (2(R)(^R′DTC)) where η²-RL is C₆H₂O-2-CHNHC₆H₄R(p)-3-Me-5, η¹-RL is C₆H₂OH-2-CHNC₆H₄R(p)-3-Me-5, R is Me, OMe, Cl, and R^′ = Me, Et, Pyr. The binding of dithiocarbamate ligand is accompanied by the dissociation of Ru-O and Ru-Cl bonds along with concomitant prototropic shift from iminium–phenolato to imine–phenol motif. The reaction also involves a sterically controlled change in rotational conformation in going to the products. The X-ray crystal structure of [Ru(η¹-ClL)(PPh₃)₂(CO)(^EtDTC)] (2(Cl)(^EtDTC)) has been described here. An account of different spectral (UV–Vis, IR, NMR) and electrochemical data of the complexes are also asserted. Density functional theory (DFT) and time-dependent density functional theory (TD-DFT) analyses were performed to scrutinize the electronic structure and the absorption spectra of the complexes. One of the dithiocarbamato complexes has also been found to have in vitro antiproliferative properties against MDA-MB-231 breast cancer cell line which was determined by MTT assay. Cell death occurs mainly through apoptosis and flow cytometric analysis indicates that the complex induces cell cycle arrest in the sub G0/G1 phase.     

Ruthenium(II) bipyridine complexes: from synthesis and crystal structures to electrochemical and cytotoxicity investigation

Complexes 1–4, [Ru(L)(bpy)₂]PF₆, where bpy = 2,2′-bipyridine; HL = 3-methylpyridine-2-carboxylic acid (HL1), 6-methylpyridine-2-carboxylic acid (HL2), 5-bromopyridine-2-carboxylic acid (HL3) and 6-bromopyridine-2-carboxylic acid (HL4), were synthesized and characterized. The electrochemical character of the complexes was investigated by cyclic voltammetry revealing two reversible reduction waves in the negative range of potentials, most likely due to a reduction of the bipyridine moiety. Cytotoxicity studies by MTT assay for 72 h of drug action revealed that 2–4 exhibited moderate activity in cervical human tumor cells (HeLa). Complex 2 exhibited low activity in colon cancer LS-174 cells (180 ± 10), while all complexes were devoid of activity in lung cancer A549 and non-tumor MRC-5 cells, up to 200 μM. Combinational studies of the most active complex 2, with pharmacological modulators of cell redox status, L-buthionine-sulfoximine (L-BSO) or N-acetyl-L-cysteine (NAC), showed that when L-BSO potentiated, 2 induced a sub-G1 peak of the cell cycle in the HeLa cell line. UV–vis and cyclic voltammetry were performed in order to investigate the binding mode of 2 to DNA and suggested intercalation for the complex–DNA interaction.     

Arene ruthenium complexes incorporating immine/azine hybrid-chelating N-N donor ligands: synthetic, spectral, structural aspects and DFT studies

New series of mono and binuclear arene ruthenium complexes [{(η⁶-arene)RuCl(L)}]⁺ and [{(η⁶-arene)RuCl}₂(μ-L)₂]²⁺ (arene=benzene, p-cymene or hexamethylbenzene), {L=pyridine-2-carbaldehyde azine (paa), p-phenylene-bis(picoline)-aldimine (pbp) and p-bi-phenylene-bis(picoline)-aldimine (bbp)} are reported. The complexes have been fully characterized and molecular structure of the representative mononuclear complex [(η⁶-C₆Me₆)RuCl(paa)]BF₄ (1), binuclear complexes [{(η⁶-C₁₀H₁₄)RuCl}₂(μ-paa)](BF₄)₂ (3) and [{(η⁶-C₁₀H₁₄)RuCl}₂(μ-pbp)](BF₄)₂ (6) have been determined by single crystal X-ray diffraction analyses. Single crystal X-ray structure determination revealed that in the binuclear complexes the [(η⁶-C₁₀H₁₄)RuCl]⁺ units are trans disposed. Further, the crystal packing in the complexes 1, 3 and 6 is stabilized by C-H?X type (X=Cl, F) inter, intramolecular hydrogen bonding and π-π stacking (3). To explore the ambiguous nature of the bonding between pyridine-2-carbaldehyde azine (paa) with ruthenium containing units [(η⁶-arene)RuCl]⁺, DFT/B3LYP calculations have been performed on the complexes [(η⁶-arene)RuCl(paa)]⁺ (arene=C₆H₆, I; C₆Me₆, II; C₁₀H₁₄, III).     

Synthesis,structural, electrochemical,and spectroscopic studies of some (diimine)ruthenium nitrile complexes

The syntheses of cationic ruthenium(II) complexes [Ru(Me₂-bpy)(PPh₃)₂RR?][PF₆]_x {Me₂-bpy = 4,4?-dimethyl-2,2?-bipyridine, (3) R = Cl, R? = N≡CMe, x = 1, (4) R = Cl, R? = N≡CPh, x = 1, (5) R = R? = N≡CMe, x = 2} and [Ru(Me₂-bpy)(κ²-dppf)RR?][PF₆]_x {dppf = 1,1?-bis(diphenylphosphino)ferrocene, (6) R = Cl, R? = N≡CMe, x = 1, (7) R = Cl, R? = N≡CPh, x = 1, (8) R = R? = N≡CMe, x = 2} are reported, together with their structural confirmation by NMR (³¹P, ¹H) and IR spectroscopy and elemental analysis, and, in the case of trans-[Ru(Me₂-bpy)(PPh₃)₂(N≡CCH₃)Cl][PF₆] (3), by X-ray crystallography. Electronic absorption and emission spectra of the complexes reveal that all complexes except 4 and 6 are emissive in the range 370–400 nm with 8 exhibiting an emission in the blue. Cyclic voltammetry studies of 3–8 show reversible or quasi-reversible redox processes at ca. 1 V, assigned to the Ru(II/III) couple.     

The first ruthenium(II) complex with benzotriazole and pyridylcarboxylato ligands

The reaction of [RuCl₂(PPh₃)₃] with 1-(2-pyridylcarbonyl)benzotriazole has been examined. A new ruthenium(II) complex–[RuCl(PPh₃)₂(C₆H₅N₃)(C₅H₄NCO₂)] has been obtained and characterized by IR and UV–Vis measurements. The crystal structure of the complex has been determined. The electronic spectrum of the complex has been calculated by TDDFT method.     

Synthesis,characterization, and electrochemical studies of Co(II,III) dithiocarbamate complexes

Cobalt(II) complexes of N-methyl phenyl, 1-phenylpiperazyl, and morpholinyl dithiocarbamates have been synthesized and characterized by UV–Visible, FTIR, ¹H-, ¹³C-NMR, and mass spectrometry. The spectroscopic data indicated that two ligands coordinated in bidentate chelating to the metal ion to form four-coordinate cobalt(II) complexes (1–3), which was confirmed by mass analysis (TOF MS ES⁺) of the complexes with m/z [M]⁺ = 450.98, 382.94, and 382.94 for 1, 2, and 3, respectively. Single crystal analysis of 2A and 3A show centrosymmetric mononuclear cobalt(III) bonded to three dithiocarbamate ligands forming a distorted octahedral geometry, indicating the cobalt(II) undergoes aerial oxidation to cobalt(III) during recrystallization. In addition, 2A crystallized with one solvated molecule of toluene. The redox behaviors of the complexes were studied by cyclic and square wave voltammetry in dichloromethane; the result revealed a metal centered redox process consisting of a one-electron quasi-reversible process assigned to Co(III)/Co(IV) oxidation and a corresponding Co(IV)/Co(III) reduction. Randles–Sevcik plots (anodic peak current versus the square root of the scan rate (I_p,a versus ν^1/2)) for the redox couples revealed diffusion-controlled behavior.     

Dendritic polyallyl and polyferrocenyl bipyridine ligands: Synthesis, MALDI-TOF characterization and ruthenium(II) complexation studies

A series of 6- and 18-armed dendritic polyallyl- and polyferrocenyl-containing bipyridine ligands were synthesized through the coupling reaction of 4,4′-bis(bromomethyl)-2,2′-bipyridine with AB₃ and AB₉ dendrons. All these bipyridine ligands were successfully characterized using standard physico-chemical techniques as well as MALDI-TOF mass spectrometric analysis. The complexation studies of these ligands toward RuCl₂(bpy)₂ indicated that, in contrast to the bulky 18-ferrocenyl bipyridine ligand 7, the 6-allyl 4 and the 18-allyl 5 bipyridine ligands react with Ru(bpy)₂Cl₂ to give the corresponding ruthenium(II) complexes 9 and 10. In the case of ligand 7, the steric bulk of the two nonaferrocenyl wedges at the 4,4′-position of the bipyridine moiety prevents the conversion of the transoid structure of the ligand to the cisiod structure needed for chelation to the metal. Thus, the 18-ferrocenyl ruthenium(II) dendrimer was not obtained. Metallodendrimers 9 and 10 have been characterized by a combination of analytical methods, especially MALDI-TOF mass spectrometric techniques. The hydrogenation of the 6-allyl ruthenium(II) dendrimer 9 in the presence of Pd/C catalyst gave the expected n-propyl complex 11. This reaction constitutes a new way for the direct synthesis of alkyl bipyridine metallodendrimers. The coordination of the alkene dendritic bipyridine ligand to the metal before the catalytic hydrogenation is absolutely necessary, because of their poisoning effect for the catalyst.     

Synthesis,spectroscopic characterization and antibacterial studies of some derivatives of chlorodimethylsulphoxide/tetramethylenesulphoxide ruthenium(II) and ruthenium(III) with 4-aminoantipyrine

We report the synthesis of five complexes of three different formulations viz. [cis-RuCl₂(4-antp)₂], [trans-RuCl₂(4-antp)₂] and [X]⁺[trans-RuCl₄(4-antp)₂]^? (X⁺ = [(DMSO)₂H]⁺, Na⁺, or [(TMSO)H]⁺ and 4-antp = 4-aminoantipyrine) from different routes. These complexes were characterized on the basis of elemental analyses, molar conductance measurements, magnetic susceptibility, electronic spectra, FTIR, ¹H-NMR and ¹³C{¹H}-NMR spectroscopy. Complexes were screened for antibacterial activity and found to be potent against gram negative bacteria Escherichia coli.     

Redox,spectroscopic, photo-induced ligand exchange,and DNA interaction studies of a new Ru(II)Pt(II) bimetallic complex

A new bimetallic complex, [Ru(biq)₂(dpp)PtCl₂](PF₆)₂ (where biq = 2,2′-biquinoline and dpp = 2,3-bis(2-pyridyl)pyrazine), containing a cis-PtCl₂ moiety coupled to a sterically strained Ru(II)-based chromophore was designed, synthesized, and investigated with respect to its spectroscopic, redox, photo-induced ligand exchange, and DNA-interaction properties. The electrochemistry of the designed complex was found to be consistent with the bridging coordination of the dpp ligand and formation of the bimetallic complex. The complex displays intense ligand-based π → π* transitions in the UV region and metal-to-ligand charge-transfer transitions (MLCT) in the visible region. The loss of bridging coordination of the dpp ligand and formation of complexes, [Ru(biq)₂(CH₃CN)₂]²⁺ and [Pt(dpp)(CH₃CN)₂]²⁺ was observed when an acetonitrile solution of the metal complex was irradiated with visible light (λ_irr ≥ 550 nm). The designed complex displays covalent binding with DNA in dark through the cis-PtCl₂ moiety, as confirmed by agarose gel electrophoresis. Upon photoirradiation, the complex dissociates into two DNA-binding moieties and displays covalent binding through: (i) a cis-PtL₂ subunit of [Ptdpp(L)₂]²⁺ and (ii) open coordination sites of the ruthenium of [Ru(biq)₂(L)₂]²⁺ (L = solvent). The designed complex represents the first Ru(II)Pt(II) complex that undergoes photo-induced ligand exchange and displays multifunctional interactions with DNA upon photoirradiation.     

Nucleophilic substitution reactions at the Si-Cl bonds of the dichloro(methyl)silyl ligand in five- and six-coordinate complexes of ruthenium(II) and osmium(II)

Treatment of either RuHCl(CO)(PPh₃)₃ or MPhCl(CO)(PPh₃)₂ with HSiMeCl₂ produces the five-coordinate dichloro(methyl)silyl complexes, M(SiMeCl₂)Cl(CO)(PPh₃)₂ (1a, M = Ru; 1b, M = Os). 1a and 1b react readily with hydroxide ions and with ethanol to give M(SiMe[OH]₂)Cl(CO)(PPh₃)₂ (2a, M = Ru; 2b, M = Os) and M(SiMe[OEt]₂)Cl(CO)(PPh₃)₂ (3a, M = Ru; 3b, M = Os), respectively. 3b adds CO to form the six-coordinate complex, Os(SiMe[OEt]₂)Cl(CO)₂(PPh₃)₂ (4b) and crystal structure determinations of 3b and 4b reveal very different Os-Si distances in the five-coordinate complex (2.3196(11) Å) and in the six-coordinate complex (2.4901(8) Å). Reaction between 1a and 1b and 8-aminoquinoline results in displacement of a triphenylphosphine ligand and formation of the six-coordinate chelate complexes M(SiMeCl₂)Cl(CO)(PPh₃)(κ²(N,N)-NC₉H₆NH₂-8) (5a, M = Ru; 5b, M = Os), respectively. Crystal structure determination of 5a reveals that the amino function of the chelating 8-aminoquinoline ligand is located adjacent to the reactive Si-Cl bonds of the dichloro(methyl)silyl ligand but no reaction between these functions is observed. However, 5a and 5b react readily with ethanol to give ultimately M(SiMe[OEt]₂)Cl(CO)(PPh₃)(κ²(N,N-NC₉H₆NH₂-8) (6a, M = Ru; 6b, M = Os). In the case of ruthenium only, the intermediate ethanolysis product Ru(SiMeCl[OEt])Cl(CO)(PPh₃)(κ²(N,N-NC₉H₆NH₂-8) (6c) was also isolated. The crystal structure of 6c was determined. Reaction between 1b and excess 2-aminopyridine results in condensation between the Si-Cl bonds and the N-H bonds with formation of a novel tridentate “NSiN” ligand in the complex Os(κ³(Si,N,N)-SiMe[NH(2-C₅H₄N)]₂)Cl(CO)(PPh₃) (7b). Crystal structure determination of 7b shows that the “NSiN” ligand coordinates to osmium with a “facial” arrangement and with chloride trans to the silyl ligand.     

Synthesis,spectral, and catalytic studies of ruthenium(II) unsymmetrical Schiff-base complexes

Unsymmetrically-substituted ruthenium(II) Schiff-base complexes, [Ru(CO)(B)(L ^x )] [B = PPh₃, AsPh₃ or Py; L ^x = dianion of tetradentate unsymmetrical Schiff-base ligand; x = 4–7, L⁴ = salen-o-hyac, L⁵ = valen-o-hyac, L⁶ = salphen-o-hyac, L⁷ = valen-2-hacn], were prepared and characterized by analytical, IR, electronic, and ¹H NMR spectral studies. The new complexes were tested for their catalytic activity towards the oxidation of benzylalcohol to benzaldehyde.     

Paramagnetic ruthenium(III) cyclometallated complex. Synthesis, spectroscopic studies and electron-transfer properties

The reaction of Ru^II(PPh₃)₃X₂ (X = Cl, Br) with o-(OH)C₆H₄C(H)=N-CH₂C₆H₅ (HL) under aerobic conditions affords Ru^II(L)₂(PPh₃)₂, 1, in which both the ligands (L) are bound to the metal center at the phenolic oxygen (deprotonated) and azomethine nitrogen and Ru^III(L¹)(L²)(PPh₃), 2, in which one L is in bidentate N,O form like in complex 1 and the other ligand is in tridentate C,N,O mode where cyclometallation takes place from the ortho carbon atom (deprotonated) of the benzyl amine fragment. The complex 1 is unstable in solution, and undergoes spontaneous oxidative internal transformation to complex 2. In solid state upon heating, 1 initially converts to 2 quantitatively and further heating causes the rearrangement of complex 2 to the stable RuL₃ complex. The presence of symmetry in the diamagnetic, electrically neutral complex 1 is confirmed by ¹H and ³¹P NMR spectroscopy. It exhibits an Ru^II → L, MLCT transition at 460 nm and a ligand based transition at 340 nm. The complex 1 undergoes quasi-reversible ruthenium(II)—ruthenium(III) oxidation at 1.27V vs. SCE. The one-electron paramagnetic cyclometallated ruthenium(III) complex 2 displays an L → Ru^III, LMCT transition at 658 nm. The ligand based transition is observed to take place at 343 nm. The complex 2 shows reversible ruthenium(III)—ruthenium(IV) oxidation at 0.875V and irreversible ruthenium(III)—ruthenium(II) reduction at −0.68V vs. SCE. It exhibits a rhombic EPR spectrum, that has been analysed to furnish values of axial (6560 cm⁻¹) and rhombic (5630 cm⁻¹) distortion parameters as well as the energies of the two expected ligand field transitions (3877 cm⁻¹ and 9540 cm⁻¹) within the t₂ shell. One of the transitions has been experimentally observed in the predicted region (9090 cm⁻¹). The first order rate constants at different temperatures and the activation parameter ΔH^#/ΔS^# values of the conversion process of 1 → 2 have been determined spectrophotometrically in chloroform solution.     

Synthesis,characterization, and cytotoxic and antimicrobial activities of ruthenium(II) arene complexes with N,N-bidentate ligands

Three new complexes, [(η⁶-C₆H₆)RuCl(C₅H₄N-2-CH=N-Ar)]PF₆ (Ar = phenylmethylene (1), (4-methoxyphenyl)methylene (2), and phenylhydrazone (3)), were prepared by reacting [(η⁶-C₆H₆)Ru(μ-Cl)Cl]₂ with N,N′-bidentate ligands in a 1 : 2 ratio. Full characterization of the complexes was accomplished using ¹H and ¹³C NMR, elemental and thermal analyses, UV–vis and IR spectroscopy and single crystal X-ray structures. Single crystal structures confirmed a pseudo-octahedral three-legged, piano-stool geometry around Ru(II), with the ligand coordinated to the ruthenium(II) through two N atoms. The cytotoxicity of the mononuclear complexes was established against three human cancer cell lines and selectivity was also tested against non-cancerous human epithelial kidney (HEK 293) cells. The compounds were selective toward the tumor cells in contrast to the known anti-cancer drug 5-fluoro uracil which was not selective between the tumor cells and non-tumor cells. All the compounds showed moderate activity against MCF7 (human breast adenocarcinoma), but showed low antiproliferative activity against Caco-2 and HepG2. Also, antimicrobial activities of the complexes were tested against a panel of antimicrobial-susceptible and -resistant Gram-negative and Gram-positive bacteria. Of special interest is the anti-mycobacterial activity of all three synthesized complexes against Mycobacterium smegmatis, and bactericidal activity against resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus ATCC 43300.